Related Experiment Videos

The global epidemic of atherosclerotic cardiovascular disease

Salim Yusuf1, Stephanie Ounpuu, Sonia Anand

  • 1Population Health Research Institute and Division of Cardiology, McMaster University, Hamilton, Ont., Canada. yusufs@fhs.mcmaster.ca

Insights

Cardiovascular diseases are a growing global health crisis, particularly in developing nations. Addressing this requires integrated strategies focusing on prevention, clinical care, and societal changes like tobacco control and promoting healthy lifestyles.

Area of Science:

  • Global Health
  • Epidemiology
  • Cardiovascular Medicine

Background:

  • Cardiovascular diseases (CVDs) represent a significant and growing cause of mortality worldwide.
  • Developing countries bear a disproportionate burden, with projections indicating 80-90% of CVDs will occur in low- and middle-income countries by 2025.
  • The rise in CVDs is attributed to factors including increased longevity, urbanization, rising obesity, and global tobacco use.

Purpose of the Study:

  • To highlight the escalating global burden of cardiovascular diseases, especially in developing nations.
  • To identify key drivers contributing to the projected increase in CVDs.
  • To emphasize the need for comprehensive strategies to combat the CVD epidemic.

Main Methods:

  • Analysis of global mortality data and disease burden trends.
  • Identification of demographic and societal factors influencing cardiovascular disease prevalence.
  • Review of current public health challenges and policy recommendations.

Main Results:

  • Developing countries face a substantial and increasing burden of cardiovascular diseases.
  • A 'double burden of disease' exists in many regions, with co-existing infections, nutritional disorders, and chronic non-communicable diseases.
  • Projected increases in CVDs are linked to demographic shifts and lifestyle changes.

Conclusions:

  • Combating the projected global CVD epidemic requires multifaceted policies.
  • Effective strategies must integrate prevention, clinical care, and resource allocation for individual and community-level interventions.
  • Societal-level changes, including tobacco control and promotion of physical activity and nutrition, are crucial.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...